These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 37429676)

  • 21. The Intestinal Microbiota in Acute Anorexia Nervosa and During Renourishment: Relationship to Depression, Anxiety, and Eating Disorder Psychopathology.
    Kleiman SC; Watson HJ; Bulik-Sullivan EC; Huh EY; Tarantino LM; Bulik CM; Carroll IM
    Psychosom Med; 2015; 77(9):969-81. PubMed ID: 26428446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protocol for faecal microbiota transplantation in irritable bowel syndrome: the MISCEAT study - a randomised, double-blind cross-over study using mixed microbiota from healthy donors.
    Hurych J; Vejmelka J; Hlinakova L; Kramna L; Larionov V; Kulich M; Cinek O; Kohout P
    BMJ Open; 2022 Jun; 12(6):e056594. PubMed ID: 35760542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protocol for faecal microbiota transplantation in ulcerative colitis (FMTUC): a randomised feasibility study.
    Jitsumura M; Cunningham AL; Hitchings MD; Islam S; Davies AP; Row PE; Riddell AD; Kinross J; Wilkinson TS; Jenkins GJ; Williams JG; Harris DA
    BMJ Open; 2018 Oct; 8(10):e021987. PubMed ID: 30341117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
    Aroniadis OC; Brandt LJ; Oneto C; Feuerstadt P; Sherman A; Wolkoff AW; Kassam Z; Sadovsky RG; Elliott RJ; Budree S; Kim M; Keller MJ
    Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):675-685. PubMed ID: 31326345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the Administration of a Lyophilised Faecal Capsules on the Intestinal Microbiome of Dogs: A Pilot Study.
    Carapeto S; Cunha E; Serrano I; Pascoal P; Pereira M; Abreu R; Neto S; Antunes B; Dias R; Tavares L; Oliveira M
    Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal analysis of the gut microbiome in adolescent patients with anorexia nervosa: microbiome-related factors associated with clinical outcome.
    Andreani NA; Sharma A; Dahmen B; Specht HE; Mannig N; Ruan V; Keller L; Baines JF; Herpertz-Dahlmann B; Dempfle A; Seitz J
    Gut Microbes; 2024; 16(1):2304158. PubMed ID: 38294867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
    Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM
    Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SPEAKS study: study protocol of a multisite feasibility trial of the Specialist Psychotherapy with Emotion for Anorexia in Kent and Sussex (SPEAKS) intervention for outpatients with anorexia nervosa or otherwise specified feeding and eating disorders, anorexia nervosa type.
    Oldershaw A; Lavender T; Basra R; Startup H
    BMJ Open; 2022 Feb; 12(2):e050350. PubMed ID: 35193902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The gut microbiome in anorexia nervosa: relevance for nutritional rehabilitation.
    Ruusunen A; Rocks T; Jacka F; Loughman A
    Psychopharmacology (Berl); 2019 May; 236(5):1545-1558. PubMed ID: 30612189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut microbiota and body composition in anorexia nervosa inpatients in comparison to athletes, overweight, obese, and normal weight controls.
    Mörkl S; Lackner S; Müller W; Gorkiewicz G; Kashofer K; Oberascher A; Painold A; Holl A; Holzer P; Meinitzer A; Mangge H; Holasek S
    Int J Eat Disord; 2017 Dec; 50(12):1421-1431. PubMed ID: 29131365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comprehensive approach to stool donor screening for faecal microbiota transplantation in China.
    He J; He X; Ma Y; Yang L; Fang H; Shang S; Xia H; Lian G; Tang H; Wang Q; Wang J; Lin Z; Wen J; Liu Y; Zhai C; Wang W; Jiang X; Xuan J; Liu M; Lu S; Li X; Wang H; Ouyang C; Cao M; Lin A; Zhang B; Wu D; Chen Y; Xiao C
    Microb Cell Fact; 2021 Nov; 20(1):216. PubMed ID: 34838016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the Firmicutes to Bacteriodetes ratio in the gut microbiome in individuals with anorexia nervosa following inpatient treatment: A systematic review and a case series.
    Helal P; Xia W; Sardar P; Conway-Morris A; Conway-Morris A; Pedicord VA; Serfontein J
    Brain Behav; 2024 Sep; 14(9):e70014. PubMed ID: 39295072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical results and microbiota changes after faecal microbiota transplantation for chronic pouchitis: a pilot study.
    Kousgaard SJ; Michaelsen TY; Nielsen HL; Kirk KF; Brandt J; Albertsen M; Thorlacius-Ussing O
    Scand J Gastroenterol; 2020 Apr; 55(4):421-429. PubMed ID: 32285709
    [No Abstract]   [Full Text] [Related]  

  • 35. PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial.
    Woodhouse CA; Patel VC; Goldenberg S; Sanchez-Fueyo A; China L; O'Brien A; Flach C; Douiri A; Shawcross D
    BMJ Open; 2019 Feb; 9(2):e023518. PubMed ID: 30772848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inpatient versus outpatient care, partial hospitalisation and waiting list for people with eating disorders.
    Hay PJ; Touyz S; Claudino AM; Lujic S; Smith CA; Madden S
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD010827. PubMed ID: 30663033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and feasibility of faecal microbiota transplant for major depressive disorder: study protocol for a pilot randomised controlled trial.
    Green JE; McGuinness AJ; Berk M; Castle D; Athan E; Hair C; Strandwitz P; Loughman A; Nierenberg AA; Cryan JF; Mohebbi M; Jacka F
    Pilot Feasibility Stud; 2023 Jan; 9(1):5. PubMed ID: 36624505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT)
    Garza-González E; Mendoza-Olazarán S; Morfin-Otero R; Ramírez-Fontes A; Rodríguez-Zulueta P; Flores-Treviño S; Bocanegra-Ibarias P; Maldonado-Garza H; Camacho-Ortiz A
    Can J Gastroenterol Hepatol; 2019; 2019():4549298. PubMed ID: 31976311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The Gut Microbiome and Its Clinical Implications in Anorexia Nervosa].
    Trinh S; Keller L; Seitz J
    Z Kinder Jugendpsychiatr Psychother; 2021 May; 50(3):227-237. PubMed ID: 34668396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of the Gut Microbiota in Anorexia Nervosa in Children and Adults-Systematic Review.
    Anton-Păduraru DT; Trofin F; Nastase EV; Miftode RS; Miftode IL; Trandafirescu MF; Cojocaru E; Țarcă E; Mindru DE; Dorneanu OS
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.